Stacey Jennifer Evans 4

4 · AUXILIUM PHARMACEUTICALS INC · Filed Sep 16, 2009

Form 4

Period: 2009-09-14

Executive VP & General Counsel

Transactions

Exercise/Conversion
Common Stock
2009-09-14$9.15/sh+1,500$13,725→ 14,715 total
Sale
Common Stock
2009-09-14$35.43/sh−6,333$224,390→ 9,382 total
Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2009-09-14−3,833→ 93,501 total
Exercise: $5.36Exp: 2015-03-16→ Common Stock (3,833 underlying)
Exercise/Conversion
Common Stock
2009-09-14$13.16/sh+1,000$13,160→ 15,715 total
Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2009-09-14−1,500→ 40,500 total
Exercise: $9.15Exp: 2016-06-06→ Common Stock (1,500 underlying)
Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2009-09-14−1,000→ 37,363 total
Exercise: $13.16Exp: 2017-02-23→ Common Stock (1,000 underlying)
Exercise/Conversion
Common Stock
2009-09-14$5.36/sh+3,833$20,545→ 13,215 total

Footnotes (4)

[F1]The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2008.
[F2]The shares underlying this option fully vested on March 16, 2009.
[F3]11,250 shares underlying this option vested on each of June 6, 2007, June 6, 2008 and June 6, 2009. The remaining 11,250 shares will vest on June 6, 2010.
[F4]10,000 shares underlying this option vested on each of February 23, 2008 and February 23, 2009. The remaining 20,000 shares will vest in two equal annual installments on February 23, 2010 and February 23, 2011.

Documents

1 file